rfhg_5376.1

Basic information about the TSS

---

TSS ID: rfhg_5376.1 TSS ID(Version3): hg_2240.1 hg_2239.1 Species: human Chr: chr1		Start: 38012707 End: 38012797 Strand: +
Source datasets	FANTOM5|PRJNA615891|PRJNA4843412|DRA013844|PRJNA401781 |PRJNA548673|PRJDB5282|PRJNA597322
Protocol	CAGE|TIF-seq2|NETCAGE|oligo_capping|SLIC_CAGE|C1CAGE |RAMPAGE|ReCappable-seq|STRIPE-seq
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2152998,EH38E1338452)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000486563.1:0 ENST00000373014.5:0 AK308377:0 AF151852:0 AF067802:0 BC005182:0 AK296018:0 AK291900:0 GeneID: 51118 HGNC/MGI_ID: HGNC:24329 UniProt_ID: Q9Y3A2 Nearer transcript ids and distances: JF432637:5 KJ898829:5 view more...

Gene_name: UTP11 small subunit processome component Gene_symbol: UTP11 Gene_synonyms: CGI-94 Gene_source: HGNC:24329

TATA-Box annotation

---

Distance to TSS:	18
Nearest PromoterID:	NM_016037
Entrez ID:	51118
Nearest Unigene:	Hs.472038
Nearest Refseq:	NM_016037
Nearest Ensembl:	ENSG00000183520
Gene Name:	UTP11 small subunit processome component
Gene Alias:	CGI-94|CGI94|UTP11L
Gene Type:	protein-coding
CpG%:	0.066667
GC%:	0.571429
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UTP11 p2@UTP11
Sample		p1@UTP11	p2@UTP11
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	87.08	30.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	73.24	28.32
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	88.54	32.21
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	82.96	32.64
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	79.64	33.97
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	89.73	40.70
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	123.10	47.50
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	119.90	40.69
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	99.81	35.26
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	46.95	24.34
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.51	18.19
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.03	20.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.66	6.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.66	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	36.23	9.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	30.43	7.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	28.61	8.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.04	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.35	8.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.53	6.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	32.45	10.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.60	8.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	23.30	7.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	34.57	9.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	35.13	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	30.77	9.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.96	10.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.08	7.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	41.98	10.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	32.87	9.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	39.66	11.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	32.71	9.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	51.79	16.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	40.20	18.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	35.83	7.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	40.06	7.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	39.69	14.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	45.92	11.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	41.53	9.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	35.76	7.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	46.55	13.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.28	12.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.79	9.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.56	13.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	48.16	12.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	34.31	10.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	40.24	12.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	33.99	9.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	42.87	10.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	47.75	12.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	53.37	9.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	713.60	139.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.58	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.12	9.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	221.48	36.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	88.63	19.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	42.13	9.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	37.26	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	97.76	16.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	35.25	9.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.96	8.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	138.53	32.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	70.67	18.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	42.56	13.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	32.66	8.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	630.39	193.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	679.18	157.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	38.51	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	49.59	6.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	35.65	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	59.28	5.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	38.98	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	35.77	3.67
Adipocyte - breast, donor1	11376-118A8	35.95	7.13
Adipocyte - breast, donor2	11327-117E4	29.52	7.86
Adipocyte - omental, donor1	11473-119C6	40.71	9.41
Adipocyte - omental, donor2	11474-119C7	25.41	6.73
Adipocyte - omental, donor3	11475-119C8	24.45	11.39
Adipocyte - perirenal, donor1	11476-119C9	24.88	5.74
Adipocyte - subcutaneous, donor1	11259-116F8	28.59	5.50
Adipocyte - subcutaneous, donor2	11336-117F4	57.81	7.68
Adipocyte - subcutaneous, donor3	11408-118E4	29.02	2.78
Adipocyte differentiation, day04, donor1	13019-139D4	66.89	9.97
Adipocyte differentiation, day04, donor2	13022-139D7	43.24	9.01
Adipocyte differentiation, day04, donor3	13025-139E1	38.75	11.71
Adipocyte differentiation, day04, donor4	13028-139E4	45.26	11.76
Adipocyte differentiation, day08, donor1	13020-139D5	87.83	15.44
Adipocyte differentiation, day08, donor2	13023-139D8	41.31	8.71
Adipocyte differentiation, day08, donor3	13026-139E2	48.52	10.13
Adipocyte differentiation, day08, donor4	13029-139E5	45.63	12.80
Adipocyte differentiation, day12, donor1	13021-139D6	38.26	9.57
Adipocyte differentiation, day12, donor2	13024-139D9	30.39	7.79
Adipocyte differentiation, day12, donor3	13027-139E3	39.92	11.78
Adipocyte differentiation, day12, donor4	13030-139E6	44.15	6.70
Alveolar Epithelial Cells, donor1	11510-119G7	46.85	5.97
Alveolar Epithelial Cells, donor2	11590-120G6	8.96	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	24.83	2.88
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	15.82	2.26
Anulus Pulposus Cell, donor1	11248-116E6	52.41	9.73
Anulus Pulposus Cell, donor2	11463-119B5	27.43	6.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.94	10.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	37.34	9.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	42.80	17.12
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.57	10.76
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	46.79	13.91
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	33.66	7.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.74	10.07
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	34.47	10.68
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.23	7.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	36.16	7.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.03	6.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	7.52
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	44.97	11.04
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	10.92
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	33.93	6.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	32.68	11.25
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	34.76	9.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	26.73	12.03
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	8.78
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	36.49	8.79
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	14.16
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	38.77	8.75
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.58	8.74
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	40.22	9.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	42.40	9.69
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	42.18	13.11
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.58	8.34
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	28.65	4.39
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	33.78	10.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.30	8.68
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	7.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	37.44	10.53
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	37.33	7.23
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	39.20	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	46.28	9.66
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	42.02	8.66
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.33	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	32.37	9.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	39.80	8.04
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.68	9.28
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	31.18	13.23
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	33.06	8.65
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	38.03	14.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	39.02	9.22
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	42.72	9.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	37.91	10.93
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	36.55	10.11
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	36.36	5.08
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	34.06	9.08
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.44	5.20
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	39.20	13.86
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.47	8.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	41.20	9.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	29.36	9.97
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	32.57	7.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.53	6.91
Astrocyte - cerebellum, donor1	11500-119F6	47.16	6.39
Astrocyte - cerebellum, donor2	11580-120F5	22.42	3.08
Astrocyte - cerebellum, donor3	11661-122F5	18.67	2.73
Astrocyte - cerebral cortex, donor1	11235-116D2	58.91	10.46
Astrocyte - cerebral cortex, donor2	11316-117D2	60.83	9.06
Astrocyte - cerebral cortex, donor3	11392-118C6	66.67	9.10
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	98.51	4.59
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	120.02	8.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	106.40	5.92
Basophils, donor1	12241-129G9	13.60	2.88
Basophils, donor2	12242-129H1	32.47	5.41
Basophils, donor3	12243-129H2	18.67	4.85
Bronchial Epithelial Cell, donor1	11511-119G8	23.29	1.94
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	14.35
Bronchial Epithelial Cell, donor4	11453-119A4	36.40	4.39
Bronchial Epithelial Cell, donor5	11457-119A8	19.13	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	15.66	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	42.65	2.70
Burkitt's lymphoma cell line:DAUDI	10422-106C8	78.73	5.98
Burkitt's lymphoma cell line:RAJI	10476-106I8	104.11	5.12
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	58.20	18.55
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	20.68
CD14+ Monocytes, donor1	11224-116B9	12.96	7.89
CD14+ Monocytes, donor2	11305-117B9	11.51	3.53
CD14+ Monocytes, donor3	11381-118B4	12.73	3.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	45.57	5.38
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.77	3.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.32	6.25
CD14+ monocytes - mock treated, donor1	11863-125A9	36.86	10.41
CD14+ monocytes - mock treated, donor2	11873-125C1	39.83	9.96
CD14+ monocytes - mock treated, donor3	11883-125D2	46.67	12.08
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.28	6.36
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	38.09	8.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	45.62	7.19
CD14+ monocytes - treated with BCG, donor1	11860-125A6	25.65	4.70
CD14+ monocytes - treated with BCG, donor2	11870-125B7	38.64	4.81
CD14+ monocytes - treated with BCG, donor3	11880-125C8	69.42	12.40
CD14+ monocytes - treated with Candida, donor1	11868-125B5	18.26	7.02
CD14+ monocytes - treated with Candida, donor2	11878-125C6	40.13	15.31
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	11.09
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	29.30	5.95
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	38.51	11.77
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	62.88	13.12
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	28.14	8.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	54.29	10.63
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.79	6.98
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.55	6.19
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	31.75	8.90
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.51	12.62
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	17.27	5.33
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	37.34	6.34
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	38.61	6.58
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	24.24	4.18
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	38.28	6.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	75.01	15.52
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.74	4.09
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	40.10	8.58
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	47.79	10.90
CD14+CD16+ Monocytes, donor1	11789-124B7	30.30	6.10
CD14+CD16+ Monocytes, donor2	11801-124D1	33.96	8.55
CD14+CD16+ Monocytes, donor3	11912-125G4	27.94	5.85
CD14+CD16- Monocytes, donor1	11788-124B6	36.44	7.32
CD14+CD16- Monocytes, donor2	11799-124C8	31.09	11.70
CD14+CD16- Monocytes, donor3	11910-125G2	44.37	9.59
CD14-CD16+ Monocytes, donor1	11790-124B8	25.77	4.34
CD14-CD16+ Monocytes, donor2	11800-124C9	27.23	5.49
CD14-CD16+ Monocytes, donor3	11911-125G3	36.42	3.79
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	43.39	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	46.91	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	39.13	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	33.69	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	39.22	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	42.19	0.00
CD19+ B Cells, donor1	11544-120B5	9.04	0.82
CD19+ B Cells, donor2	11624-122B4	12.33	0.00
CD19+ B Cells, donor3	11705-123B4	20.70	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	113.54	8.49
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	79.10	5.59
CD34+ Progenitors, donor1	11545-120B6	26.11	15.06
CD34+ Progenitors, donor2	11625-122B5	38.76	16.29
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	68.76	19.92
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	82.98	18.94
CD4+ T Cells, donor1	11225-116C1	28.21	6.43
CD4+ T Cells, donor2	11306-117C1	17.76	4.90
CD4+ T Cells, donor3	11382-118B5	16.16	4.88
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	63.30	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	60.87	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	52.03	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.55	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	30.20	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	47.11	2.60
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.33	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	36.11	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	33.17	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	29.70	3.84
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	32.12	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	56.08	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	42.39	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	34.08	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	21.48	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	29.48	5.36
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	59.34	2.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	63.90	3.47
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	47.91	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	22.75	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.43	3.90
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.27	5.23
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	51.47	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	55.39	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	48.85	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	72.28	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	82.45	5.64
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	63.03	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	54.01	1.38
CD8+ T Cells, donor1	11226-116C2	22.59	1.96
CD8+ T Cells, donor2	11307-117C2	27.78	4.51
CD8+ T Cells, donor3	11383-118B6	19.44	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	45.65	3.44
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	46.49	2.88
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	46.78	4.65
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	75.35	6.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	40.32	2.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	47.30	5.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	46.50	4.78
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	43.96	4.47
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	49.48	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	46.19	4.83
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	47.06	4.94
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	54.09	4.26
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	42.02	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	36.43	5.01
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.80	8.20
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	53.66	4.32
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	57.54	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	40.54	5.19
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	77.32	7.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	55.36	3.69
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	55.78	4.17
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	44.75	5.35
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	40.59	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.77	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	40.95	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.27	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	44.08	1.00
Cardiac Myocyte, donor1	11525-119I4	87.73	20.11
Cardiac Myocyte, donor2	11605-120I3	40.02	12.35
Cardiac Myocyte, donor3	11686-122I3	63.67	9.26
Chondrocyte - de diff, donor1	11261-116G1	81.47	10.75
Chondrocyte - de diff, donor2	11338-117F6	30.92	6.40
Chondrocyte - de diff, donor3	11410-118E6	26.51	9.10
Chondrocyte - re diff, donor2	11339-117F7	94.00	17.91
Chondrocyte - re diff, donor3	11411-118E7	25.88	4.85
Ciliary Epithelial Cells, donor1	11242-116D9	78.61	15.15
Ciliary Epithelial Cells, donor2	11323-117D9	50.88	11.12
Ciliary Epithelial Cells, donor3	11399-118D4	53.98	9.29
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	38.24	5.87
Corneal Epithelial Cells, donor1	11526-119I5	18.00	0.88
Corneal Epithelial Cells, donor2	11606-120I4	21.61	4.55
Corneal Epithelial Cells, donor3	11687-122I4	28.37	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	24.43	3.14
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	28.39	4.73
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.43	3.56
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.01	11.27
Dendritic Cells - plasmacytoid, donor2	11309-117C4	35.91	10.45
Dendritic Cells - plasmacytoid, donor3	11385-118B8	38.72	15.00
Endothelial Cells - Aortic, donor0	11207-116A1	41.03	7.00
Endothelial Cells - Aortic, donor1	11263-116G3	39.90	4.11
Endothelial Cells - Aortic, donor2	11340-117F8	40.72	5.09
Endothelial Cells - Aortic, donor3	11412-118E8	27.92	5.11
Endothelial Cells - Artery, donor1	11264-116G4	25.02	4.07
Endothelial Cells - Artery, donor2	11341-117F9	51.53	6.35
Endothelial Cells - Artery, donor3	11413-118E9	43.30	4.03
Endothelial Cells - Lymphatic, donor1	11236-116D3	47.43	12.86
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.16	9.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	48.21	11.28
Endothelial Cells - Microvascular, donor1	11265-116G5	26.74	6.24
Endothelial Cells - Microvascular, donor2	11342-117G1	38.53	6.25
Endothelial Cells - Microvascular, donor3	11414-118F1	14.04	4.11
Endothelial Cells - Thoracic, donor1	11266-116G6	92.03	13.60
Endothelial Cells - Thoracic, donor2	11343-117G2	29.88	9.96
Endothelial Cells - Umbilical vein, donor1	11243-116E1	108.96	26.46
Endothelial Cells - Umbilical vein, donor2	11324-117E1	77.13	19.12
Endothelial Cells - Umbilical vein, donor3	11400-118D5	80.60	13.19
Endothelial Cells - Vein, donor1	11267-116G7	23.89	5.69
Endothelial Cells - Vein, donor2	11344-117G3	29.34	2.79
Endothelial Cells - Vein, donor3	11416-118F3	32.81	6.75
Eosinophils, donor1	12244-129H3	45.74	0.00
Eosinophils, donor2	12245-129H4	18.15	1.65
Eosinophils, donor3	12246-129H5	10.70	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	20.03	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	47.62	8.62
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.07	4.27
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	34.99	8.23
Fibroblast - Aortic Adventitial, donor1	11245-116E3	69.01	13.95
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.68	5.19
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.18	6.64
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	36.63	8.17
Fibroblast - Aortic Adventitial, donor3	11401-118D6	62.12	10.63
Fibroblast - Cardiac, donor1	11268-116G8	43.09	6.80
Fibroblast - Cardiac, donor2	11345-117G4	33.35	4.55
Fibroblast - Cardiac, donor3	11417-118F4	26.34	7.25
Fibroblast - Cardiac, donor4	11452-119A3	73.05	10.91
Fibroblast - Cardiac, donor5	11456-119A7	48.60	11.68
Fibroblast - Cardiac, donor6	11460-119B2	59.73	13.04
Fibroblast - Choroid Plexus, donor1	11492-119E7	42.47	7.64
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.79	10.79
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	63.66	4.61
Fibroblast - Conjunctival, donor3	11692-122I9	52.41	25.10
Fibroblast - Dermal, donor1	11269-116G9	45.08	2.58
Fibroblast - Dermal, donor2	11346-117G5	59.43	3.77
Fibroblast - Dermal, donor3	11418-118F5	52.46	5.92
Fibroblast - Dermal, donor4	11450-119A1	69.98	6.33
Fibroblast - Dermal, donor5	11454-119A5	80.07	8.37
Fibroblast - Dermal, donor6	11458-119A9	92.74	12.99
Fibroblast - Gingival, donor1	11237-116D4	69.34	8.12
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.54	8.12
Fibroblast - Gingival, donor2	11318-117D4	68.66	6.59
Fibroblast - Gingival, donor3	11394-118C8	45.06	6.38
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	57.14	10.39
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.44	5.46
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	74.67	10.13
Fibroblast - Gingival, donor6 (control)	11922-125H5	53.41	8.65
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.64	4.59
Fibroblast - Gingival, donor7 (control)	11924-125H7	67.56	13.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	65.45	12.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	108.82	18.76
Fibroblast - Gingival, donor9 (control)	11927-125I1	46.22	8.66
Fibroblast - Lung, donor1	11270-116H1	21.75	5.44
Fibroblast - Lung, donor2	11347-117G6	71.62	17.91
Fibroblast - Lung, donor3	11419-118F6	49.38	7.18
Fibroblast - Lymphatic, donor1	11506-119G3	44.15	8.33
Fibroblast - Lymphatic, donor2	11586-120G2	29.37	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	9.24	1.68
Fibroblast - Mammary, donor1	11540-120B1	77.95	10.15
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	86.71	10.28
Fibroblast - Periodontal Ligament, donor2	11319-117D5	82.82	7.89
Fibroblast - Periodontal Ligament, donor3	11395-118C9	101.59	9.18
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	61.06	6.11
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	38.34	7.29
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	35.49	5.80
Fibroblast - Pulmonary Artery, donor1	11250-116E8	98.93	15.59
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	71.73	6.71
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.75	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	39.14	5.93
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	53.58	7.54
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.94	8.70
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	64.45	13.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	43.62	5.42
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	67.90	15.01
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	42.52	5.31
Fibroblast - skin normal, donor1	11553-120C5	47.42	6.73
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	80.80	9.22
Fibroblast - skin normal, donor2	11561-120D4	70.42	12.36
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	57.73	12.09
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	44.24	11.52
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	59.32	15.21
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	36.13	8.54
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	71.58	10.65
Fibroblast - skin walker warburg, donor1	11554-120C6	57.86	9.61
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	58.34	12.39
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1706.30	243.76
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	49.68	16.56
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	49.58	5.55
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	64.02	5.73
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	65.67	6.90
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	71.96	21.44
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	86.14	21.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	154.90	26.53
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	50.19	6.62
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.92	5.02
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	89.95	15.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	56.04	7.14
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	47.62	4.89
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	122.05	23.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	68.97	14.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.60	11.45
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	60.71	16.39
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	66.04	12.76
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	69.77	12.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	63.84	16.67
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	50.88	8.67
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	54.56	8.72
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	49.40	10.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.94	12.71
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	55.79	10.81
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	60.55	8.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	46.58	12.30
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	63.45	10.52
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	80.34	17.03
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	80.33	12.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	85.39	14.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	56.43	8.63
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	78.29	12.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	88.21	18.17
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	46.21	8.05
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	51.42	7.72
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.53	7.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.87	7.94
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.49	9.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	55.44	11.18
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	40.73	7.06
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	40.84	5.02
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	47.45	8.54
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	47.74	8.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	48.40	9.09
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.47	10.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.15	7.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	45.74	6.57
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	47.60	11.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	51.10	8.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	51.69	7.64
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	52.59	8.67
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	46.83	9.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.94	8.33
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	46.61	9.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	40.63	8.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	37.73	7.87
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	72.94	13.22
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	129.79	32.45
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	80.12	11.86
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	102.29	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	75.73	17.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	72.90	16.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	78.87	15.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	94.04	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	81.62	21.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	81.83	11.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	57.38	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	68.68	12.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	79.89	17.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	59.98	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	66.84	10.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	62.75	10.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	61.24	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.39	10.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	60.12	10.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	71.00	14.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	67.01	14.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	41.73	7.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	79.62	18.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	75.39	14.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	68.58	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	49.59	14.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	57.37	13.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	48.16	12.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	54.32	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	72.92	18.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	14.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	62.76	8.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	47.68	6.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	60.02	11.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	60.62	11.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.84	12.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	62.56	11.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	41.42	9.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	52.23	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	49.54	10.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	46.58	14.56
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	23.97	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.03	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	23.61	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	34.25	5.71
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.06	5.85
Hep-2 cells mock treated, biol_rep1	11898-125E8	75.78	11.02
Hep-2 cells mock treated, biol_rep2	11899-125E9	70.90	14.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	77.12	10.69
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	80.56	9.84
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.93	9.89
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	69.32	7.97
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	52.31	10.46
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	49.41	8.06
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	45.49	10.25
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	26.30	4.48
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.80	3.90
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	15.86
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	37.74	3.17
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	6.54
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	61.72	12.94
Hepatocyte, donor1	11523-119I2	30.27	2.42
Hepatocyte, donor2	11603-120I1	35.55	15.08
Hepatocyte, donor3	11684-122I1	33.74	10.43
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	72.45	20.23
Intestinal epithelial cells (polarized), donor1	11246-116E4	34.26	6.47
Iris Pigment Epithelial Cells, donor1	11530-119I9	71.07	10.43
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	79.60	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	53.99	11.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	66.64	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	61.72	9.75
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	71.69	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	50.29	7.94
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	67.63	11.09
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	55.43	8.82
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	54.13	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	65.25	5.81
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	59.57	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	62.75	5.70
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	33.17	2.94
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	69.92	10.45
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	65.55	5.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	69.86	6.14
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	61.67	4.53
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	59.19	12.91
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	64.79	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	59.30	5.10
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	52.86	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	47.41
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	61.41	5.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	70.07	11.42
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	84.29	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	84.86	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	66.76	6.26
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	44.26	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	12.97
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	42.72	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	36.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	41.60	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	54.03	11.08
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	76.94	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	35.90	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	39.12	5.29
Keratinocyte - epidermal, donor1	11272-116H3	48.31	3.10
Keratinocyte - epidermal, donor2	11349-117G8	28.70	0.59
Keratinocyte - epidermal, donor3	11421-118F8	72.13	4.45
Keratinocyte - oral, donor1	11251-116E9	82.41	6.36
Keratocytes, donor1	11527-119I6	100.05	3.78
Keratocytes, donor2	11607-120I5	38.67	2.34
Keratocytes, donor3	11688-122I5	54.54	4.74
Krukenberg tumor cell line:HSKTC	10687-109F3	125.28	4.40
Lens Epithelial Cells, donor1	11529-119I8	49.62	4.31
Lens Epithelial Cells, donor2	11609-120I7	61.47	8.30
Lens Epithelial Cells, donor3	11690-122I7	58.02	10.80
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	42.09	6.88
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	18.42	5.58
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	44.08	13.22
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.04	7.53
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.38	4.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.81	5.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.11	8.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.89	2.78
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.97	6.47
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	25.31	7.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.40	8.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.11	2.59
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.34	5.57
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	21.71	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.39	5.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.11	9.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.59	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.59	4.03
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.67	5.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.40	4.69
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.68	7.22
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	42.68	8.73
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.58	8.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.52	9.08
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	7.78
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	31.62	7.12
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	23.46	6.17
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.83	12.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.02	5.83
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.86	3.29
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	30.53	6.78
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.83	4.96
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.84	5.08
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	39.61	7.77
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.66	8.89
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.77	5.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	31.20	7.08
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	32.26	8.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	29.39	12.04
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	34.49	9.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.06	6.79
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.07	4.67
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.09	8.59
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	23.85	6.53
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.83	3.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	47.03	6.93
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.06	3.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.15	6.86
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.95	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	21.52	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.04	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	19.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	11.34	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	7.14
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.26	3.39
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.08	4.94
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.76	6.75
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.05	3.25
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	25.41	3.53
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	26.65	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	18.85	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	36.02	3.20
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.85	5.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	12.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	36.44	7.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	30.55	7.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	22.67	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	26.71	6.10
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	26.31	3.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.22	4.98
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.17	4.60
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.81	5.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.71	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.65	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	24.85	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.11	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	29.13	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.07	4.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.68	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.97	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.32	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.29	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	26.12	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.37	4.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	16.92	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.81	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.81	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.86	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.24	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	5.65
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.62	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.63	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	21.82	4.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.12	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	20.45	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.62	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.94	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.36	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.17	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.69	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	25.32	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	26.43	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.87	5.17
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.27	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	23.52	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.46	5.70
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.72	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.72	5.44
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	27.89	5.39
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	25.06	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.67	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.63	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.93	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.37	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	17.06	3.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.93	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	24.22	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	22.77	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	30.11	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.39	4.28
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.27	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	32.48	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	26.26	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.50	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	28.86	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	28.51	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	2.08
Macrophage - monocyte derived, donor1	11232-116C8	38.52	2.28
Macrophage - monocyte derived, donor2	11313-117C8	52.30	2.20
Macrophage - monocyte derived, donor3	11389-118C3	37.49	2.62
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	52.04	4.78
Mallassez-derived cells, donor2	11929-125I3	65.12	4.91
Mallassez-derived cells, donor3	11930-125I4	100.49	8.62
Mammary Epithelial Cell, donor1	11273-116H4	83.60	6.38
Mammary Epithelial Cell, donor2	11350-117G9	77.02	4.92
Mammary Epithelial Cell, donor3	11422-118F9	20.20	2.24
Mast cell - stimulated, donor1	11487-119E2	191.86	14.24
Mast cell, donor1	11563-120D6	62.40	5.30
Mast cell, donor2	11565-120D8	40.12	3.57
Mast cell, donor3	11566-120D9	36.92	5.18
Mast cell, donor4	11567-120E1	32.80	2.66
Mast cell, expanded and stimulated, donor5	11940-126A5	80.84	2.77
Mast cell, expanded and stimulated, donor8	11942-126A7	83.47	11.67
Mast cell, expanded, donor5	11939-126A4	52.43	3.21
Mast cell, expanded, donor8	11941-126A6	47.70	4.35
Melanocyte - dark, donor1	11502-119F8	72.73	19.60
Melanocyte - dark, donor2	11582-120F7	43.61	15.23
Melanocyte - dark, donor3	11663-122F7	135.39	16.81
Melanocyte - light, donor1	11274-116H5	17.87	1.65
Melanocyte - light, donor2	11351-117H1	15.01	2.73
Melanocyte - light, donor3	11423-118G1	19.08	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	73.62	4.69
Melanocyte, donor2 (MC+2)	12739-135I3	70.73	16.67
Melanocyte, donor3 (MC+3)	12837-137B2	61.07	5.89
Meningeal Cells, donor1	11493-119E8	90.32	7.94
Meningeal Cells, donor2	11573-120E7	46.66	6.60
Meningeal Cells, donor3	11654-122E7	134.23	13.45
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	81.84	13.69
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	43.27	8.15
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	94.72	10.76
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	49.98	11.44
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.67	7.54
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	43.51	3.74
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	39.45	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	30.49	2.05
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	51.94	9.56
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	21.19	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	61.18	11.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.44	5.64
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	38.42	8.33
Mesenchymal stem cells - adipose, donor0	11217-116B2	149.58	17.37
Mesenchymal stem cells - hepatic, donor0	11218-116B3	53.48	10.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	80.55	10.16
Mesothelial Cells, donor1	11247-116E5	50.91	6.63
Mesothelial Cells, donor2	12156-128G5	34.53	8.01
Mesothelial Cells, donor3	11402-118D7	34.54	5.20
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	36.46	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	51.23	3.20
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.40	3.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.40	2.48
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.29	2.90
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.79	4.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.89	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.75	2.64
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	31.28	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	29.26	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	23.34	4.67
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.99	2.09
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.83	3.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	25.91	2.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.16	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	27.63	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	26.08	3.79
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.52	3.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.32	4.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	27.79	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.77	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.74	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	21.47	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	16.76	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	15.38	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.61	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.02	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.33	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	18.76	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.69	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.27	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	27.35	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	29.83	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.49	2.52
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.44	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.39	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.31	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.97	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	18.47	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.78	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	32.61	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.62	3.89
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.03	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.28	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	29.93	4.49
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	29.10	2.83
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	28.03	4.46
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.52	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.58	2.28
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	35.80	3.41
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	29.00	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.67	3.91
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	36.75	4.12
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.45	5.48
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	38.33	6.18
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.10	2.38
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	37.79	4.93
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.23	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	49.19	4.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.90	3.46
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	46.94	5.88
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.94	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	56.12	12.29
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	45.12	4.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	8.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.35	7.63
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	10.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	7.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	61.83	9.26
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	47.04	9.93
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	39.38	4.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.15	3.76
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	137.85	14.83
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	237.78	36.70
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	23.80	5.44
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	275.65	29.40
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.58	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	46.95	2.79
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	32.70	8.38
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	40.58	8.83
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	478.79	211.56
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	38.44	8.12
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.98	3.63
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.03	4.74
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	45.02	9.66
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.17	5.30
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	6.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	96.81	27.90
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.44	5.04
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	54.68	14.82
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	6.44
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.85	8.35
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	92.09	20.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	300.89	60.68
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	49.46	9.13
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	26.25	5.93
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	34.18	8.07
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	26.18	7.30
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	613.89	144.44
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.99	4.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	32.01	6.31
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	21.03	6.75
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	27.86	12.07
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.40	6.43
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	2.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.48	3.92
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	46.59	7.69
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	26.46	10.58
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	24.60	8.64
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	28.27	10.42
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	26.80	4.21
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	33.87	6.35
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	46.86	5.75
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.68	4.74
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	270.81	45.99
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	6.71
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.55	2.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.54	6.36
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.82	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	105.43	20.41
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	268.07	65.75
Myoblast, donor1	11241-116D8	59.75	8.94
Myoblast, donor2	11322-117D8	57.54	9.01
Myoblast, donor3	11398-118D3	80.05	8.24
NK T cell leukemia cell line:KHYG-1	10777-110G3	101.13	3.06
Natural Killer Cells, donor1	11230-116C6	27.98	4.92
Natural Killer Cells, donor2	11311-117C6	21.41	5.43
Natural Killer Cells, donor3	11387-118C1	23.37	4.42
Neural stem cells, donor1	11275-116H6	119.77	31.21
Neural stem cells, donor2	11352-117H2	121.32	23.11
Neurons, donor1	11494-119E9	86.48	35.27
Neurons, donor2	11574-120E8	96.87	15.19
Neurons, donor3	11655-122E8	130.72	43.57
Neutrophils, donor1	11233-116C9	4.64	0.93
Neutrophils, donor2	11314-117C9	5.80	0.00
Neutrophils, donor3	11390-118C4	9.77	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	55.69	13.06
Nucleus Pulposus Cell, donor2	11409-118E5	18.56	5.54
Nucleus Pulposus Cell, donor3	11462-119B4	40.31	5.41
Olfactory epithelial cells, donor1	11933-125I7	33.31	7.16
Olfactory epithelial cells, donor2	11934-125I8	46.46	8.68
Olfactory epithelial cells, donor3	11935-125I9	40.41	6.92
Olfactory epithelial cells, donor4	11936-126A1	37.01	5.26
Oligodendrocyte - precursors, donor1	11496-119F2	96.29	5.42
Osteoblast - differentiated, donor1	11276-116H7	32.97	4.89
Osteoblast - differentiated, donor2	11353-117H3	14.86	4.57
Osteoblast - differentiated, donor3	11425-118G3	18.62	3.72
Osteoblast, donor1	11277-116H8	37.13	4.50
Osteoblast, donor2	11354-117H4	92.71	25.99
Osteoblast, donor3	11426-118G4	38.39	6.22
Pancreatic stromal cells, donor1	11249-116E7	67.64	10.78
Pericytes, donor1	11491-119E6	22.59	3.00
Pericytes, donor2	11571-120E5	25.35	4.30
Pericytes, donor3	11652-122E5	22.38	1.63
Perineurial Cells, donor1	11499-119F5	76.06	10.17
Perineurial Cells, donor2	11579-120F4	71.49	20.06
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	26.46	6.06
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	10.28	5.14
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.73	2.98
Placental Epithelial Cells, donor1	11278-116H9	26.07	2.39
Placental Epithelial Cells, donor2	11355-117H5	27.72	2.22
Placental Epithelial Cells, donor3	11427-118G5	15.31	1.96
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	23.73	7.91
Preadipocyte - breast, donor1	11467-119B9	31.51	8.63
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.81	4.83
Preadipocyte - breast, donor2	11328-117E5	31.75	6.75
Preadipocyte - omental, donor1	11468-119C1	39.53	9.48
Preadipocyte - omental, donor2	11329-117E6	35.35	4.80
Preadipocyte - omental, donor3	11403-118D8	43.12	5.59
Preadipocyte - perirenal, donor1	11469-119C2	15.75	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	25.18	3.07
Preadipocyte - subcutaneous, donor2	11356-117H6	101.82	12.57
Preadipocyte - subcutaneous, donor3	11428-118G6	70.33	10.73
Preadipocyte - visceral, donor1	11280-116I2	121.37	14.34
Preadipocyte - visceral, donor2	11357-117H7	60.28	7.82
Preadipocyte - visceral, donor3	11429-118G7	72.41	8.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	57.02	8.45
Prostate Epithelial Cells, donor2	11331-117E8	26.27	2.17
Prostate Epithelial Cells, donor3	11404-118D9	23.76	1.35
Prostate Stromal Cells, donor1	11254-116F3	71.07	7.75
Prostate Stromal Cells, donor2	11332-117E9	57.91	8.79
Prostate Stromal Cells, donor3	11405-118E1	36.91	6.99
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.55	2.92
Renal Cortical Epithelial Cells, donor2	11596-120H3	50.53	2.98
Renal Epithelial Cells, donor1	11517-119H5	15.72	1.01
Renal Epithelial Cells, donor2	11597-120H4	18.49	0.71
Renal Epithelial Cells, donor3	11678-122H4	70.61	5.61
Renal Glomerular Endothelial Cells, donor1	11514-119H2	22.47	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.22	5.12
Renal Glomerular Endothelial Cells, donor3	11675-122H1	62.83	12.43
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	2.00
Renal Mesangial Cells, donor1	11518-119H6	34.77	2.20
Renal Mesangial Cells, donor2	11598-120H5	23.20	5.64
Renal Mesangial Cells, donor3	11679-122H5	9.15	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	41.87	4.56
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	17.71	2.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.83	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	71.56	6.74
Retinal Pigment Epithelial Cells, donor1	11528-119I7	36.67	3.13
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	44.41	9.53
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	46.10	6.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	62.54	10.72
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	139.79	18.16
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	118.91	15.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	102.98	9.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	56.41	5.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	86.22	9.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	85.09	10.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	65.85	5.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	71.19	9.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	62.84	8.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	63.23	7.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	62.00	6.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	54.94	6.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.66	6.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	64.17	7.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	57.74	8.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	62.51	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	97.52	12.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	70.20	8.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	67.46	6.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	72.76	8.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	66.32	9.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	61.95	6.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	72.46	7.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	65.82	6.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	62.05	6.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	68.37	6.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	64.16	13.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	59.52	8.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	70.39	11.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	66.35	9.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	64.37	9.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	70.81	6.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	64.20	9.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	87.36	10.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	70.95	11.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	66.54	9.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	65.02	7.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	69.61	9.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	54.37	5.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	59.92	6.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	55.71	5.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	55.31	7.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	47.14	8.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	74.77	10.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	43.32	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.50	9.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	47.45	9.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	39.16	8.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	107.85	22.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	56.58	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	37.37	9.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.92	6.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.63	4.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	51.83	9.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	45.04	6.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	45.67	9.01
Schwann Cells, donor1	11498-119F4	26.33	4.14
Schwann Cells, donor2	11578-120F3	54.44	10.21
Schwann Cells, donor3	11659-122F3	44.91	8.54
Sebocyte, donor1	11220-116B5	47.66	1.64
Sebocyte, donor2	11301-117B5	44.12	2.30
Sebocyte, donor3	11378-118B1	23.70	2.27
Sertoli Cells, donor1	11255-116F4	53.01	4.97
Sertoli Cells, donor2	11333-117F1	33.89	5.65
Skeletal Muscle Cells, donor1	11281-116I3	50.76	10.73
Skeletal Muscle Cells, donor2	11358-117H8	19.52	5.78
Skeletal Muscle Cells, donor3	11430-118G8	50.16	1.67
Skeletal Muscle Cells, donor4	11451-119A2	90.80	13.20
Skeletal Muscle Cells, donor5	11455-119A6	80.12	12.19
Skeletal Muscle Cells, donor6	11459-119B1	115.73	13.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	75.60	15.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	56.93	8.13
Skeletal Muscle Satellite Cells, donor3	11397-118D2	108.44	13.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	76.25	18.11
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	22.98	4.27
Skin - palm, donor1	10286-104F7	51.04	24.17
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	26.52	4.04
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	75.25	5.73
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	31.16	3.76
Small Airway Epithelial Cells, donor1	11256-116F5	48.79	4.87
Small Airway Epithelial Cells, donor2	11334-117F2	37.41	3.80
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	87.12	6.55
Small Airway Epithelial Cells, donor3	11406-118E2	25.71	1.50
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	31.48	7.41
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	27.57	3.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.98	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	21.22	1.99
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.20	3.94
Smooth Muscle Cells - Aortic, donor3	11432-118H1	31.68	5.41
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	14.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	26.08	4.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	55.41	9.31
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	39.69	7.04
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	56.98	8.47
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	67.04	12.11
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.74	4.98
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.63	1.63
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	44.14	6.39
Smooth Muscle Cells - Carotid, donor1	11285-116I7	33.34	6.06
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	23.36	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	66.22	8.26
Smooth Muscle Cells - Colonic, donor2	11320-117D6	52.73	7.96
Smooth Muscle Cells - Colonic, donor3	11396-118D1	63.39	10.29
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	34.49	2.01
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	28.02	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	24.81	3.59
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	29.70	5.46
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	57.48	13.82
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	50.62	5.13
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	45.74	4.32
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.70	4.83
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	191.54	18.01
Smooth Muscle Cells - Prostate, donor1	11257-116F6	75.23	9.85
Smooth Muscle Cells - Prostate, donor2	11335-117F3	49.21	6.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	39.32	11.41
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	54.13	6.63
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.58	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	46.95	6.56
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	25.38	3.76
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	23.89	3.24
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	120.30	10.16
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	46.72	11.21
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.92	2.16
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	40.79	4.59
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.02	2.82
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	119.76	16.07
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	63.76	9.64
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	27.89	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	94.34	13.26
Smooth Muscle Cells - Uterine, donor3	11466-119B8	59.39	7.61
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	39.26	10.50
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	40.46	5.82
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	69.55	11.53
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	39.53	6.83
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	46.56	3.12
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	86.65	10.63
Smooth muscle cells - airway, control, donor1	11966-126D4	55.36	10.67
Smooth muscle cells - airway, control, donor2	11967-126D5	26.75	7.19
Smooth muscle cells - airway, control, donor3	11968-126D6	41.38	4.60
Smooth muscle cells - airway, control, donor4	11969-126D7	38.96	8.71
Synoviocyte, donor1	11291-117A4	55.55	13.13
Synoviocyte, donor2	11368-117I9	30.17	8.88
Synoviocyte, donor3	11440-118H9	26.14	6.70
Trabecular Meshwork Cells, donor1	11532-120A2	51.10	5.72
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	29.64	2.08
Tracheal Epithelial Cells, donor1	11292-117A5	40.57	3.51
Tracheal Epithelial Cells, donor2	11369-118A1	17.78	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	16.61	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	40.47	9.72
Urethra, donor2	10319-105A4	50.36	12.59
Urothelial Cells, donor1	11520-119H8	19.66	1.33
Urothelial Cells, donor2	11600-120H7	12.42	0.40
Urothelial Cells, donor3	11681-122H7	9.17	0.69
Urothelial cells, donor0	11216-116B1	54.16	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	37.37	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	45.75	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.17	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	31.68	4.82
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.05	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	36.44	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	46.81	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	24.65	4.56
Wilms' tumor cell line:G-401	10809-111A8	72.17	5.43
Wilms' tumor cell line:HFWT	10597-108E3	56.32	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	58.94	6.70
achilles tendon, donor2	10292-104G4	28.93	22.73
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	105.55	5.61
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	143.02	12.54
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	83.33	14.01
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	200.00	25.31
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	119.74	9.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	101.09	33.41
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	84.66	37.57
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	86.37	16.30
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	86.57	21.64
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	85.43	13.98
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	126.04	14.54
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	89.71	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	106.66	27.19
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	127.64	8.28
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	83.58	4.97
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	63.21	5.58
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	101.17	8.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.95	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	104.12	6.83
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	88.87	6.67
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	114.58	9.63
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	118.05	20.05
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	135.75	8.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	211.84	22.30
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	145.77	19.21
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	73.71	29.22
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	226.81	46.86
adenocarcinoma cell line:IM95m	10796-110I4	66.65	9.66
adipose tissue, adult, pool1	10010-101C1	43.28	16.91
adipose, donor1	10184-103D4	163.02	14.66
adipose, donor2	10185-103D5	34.87	3.24
adipose, donor3	10186-103D6	55.27	6.53
adipose, donor4	10187-103D7	79.74	8.67
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	121.99	6.79
adrenal gland, adult, pool1	10081-102A9	36.38	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	79.24	6.94
alveolar cell carcinoma cell line:SW 1573	10708-109H6	123.63	11.08
amniotic membrane cells, donor1	12235-129G3	39.65	9.74
amniotic membrane cells, donor2	12236-129G4	38.88	4.73
amniotic membrane cells, donor3	12237-129G5	26.81	5.60
amygdala - adult, donor10196	10167-103B5	67.59	10.67
amygdala, adult, donor10252	10151-102I7	47.24	8.92
amygdala, newborn, donor10223	10360-105E9	44.86	5.81
anaplastic carcinoma cell line:8305C	10428-106D5	59.46	9.55
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	104.13	12.35
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	83.84	15.37
aorta, adult, pool1	10052-101G7	20.59	7.65
appendix, adult	10189-103D9	41.92	6.60
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	62.25	21.32
artery, adult	10190-103E1	127.72	118.21
astrocytoma cell line:TM-31	10425-106D2	82.43	16.80
b cell line:RPMI1788	10427-106D4	46.39	3.42
basal cell carcinoma cell line:TE 354.T	10702-109G9	49.94	5.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	73.63	9.63
bile duct carcinoma cell line:TFK-1	10496-107C1	38.33	2.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	57.04	12.86
bladder, adult, pool1	10011-101C2	83.76	33.35
blood, adult, pool1	10053-101G8	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.10	9.42
bone marrow, adult	10192-103E3	57.36	12.82
brain, adult, donor1	10084-102B3	24.60	4.10
brain, adult, pool1	10012-101C3	55.46	7.57
brain, fetal, pool1	10085-102B4	37.40	8.01
breast carcinoma cell line:MCF7	10482-107A5	81.27	18.17
breast carcinoma cell line:MDA-MB-453	10419-106C5	88.12	4.12
breast, adult, donor1	10080-102A8	32.20	10.73
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	68.22	3.56
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	89.98	9.28
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	100.15	9.21
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	58.58	4.60
carcinoid cell line:NCI-H1770	10703-109H1	172.08	13.63
carcinoid cell line:NCI-H727	10735-110B6	40.03	4.59
carcinoid cell line:SK-PN-DW	10719-109I8	78.59	13.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	113.39	15.70
caudate nucleus - adult, donor10196	10177-103C6	88.65	14.97
caudate nucleus, adult, donor10252	10164-103B2	40.66	4.52
caudate nucleus, adult, donor10258	10379-105H1	39.74	6.88
caudate nucleus, newborn, donor10223	10354-105E3	36.99	8.79
cerebellum - adult, donor10196	10173-103C2	78.66	14.57
cerebellum, adult, donor10252	10166-103B4	58.72	4.06
cerebellum, adult, pool1	10083-102B2	30.70	1.72
cerebellum, newborn, donor10223	10357-105E6	49.82	8.30
cerebral meninges, adult	10188-103D8	55.97	10.09
cerebrospinal fluid, donor2	10294-104G6	69.43	73.09
cervical cancer cell line:D98-AH2	10552-107I3	82.67	12.37
cervical cancer cell line:ME-180	10553-107I4	52.20	3.48
cervix, adult, pool1	10013-101C4	58.90	16.38
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	108.27	10.03
chondrosarcoma cell line:SW 1353	10700-109G7	53.56	11.76
choriocarcinoma cell line:BeWo	10423-106C9	71.96	17.15
choriocarcinoma cell line:SCH	10785-110H2	60.25	6.04
choriocarcinoma cell line:T3M-3	10618-108G6	48.15	8.78
chorionic membrane cells, donor1	12238-129G6	24.79	7.12
chorionic membrane cells, donor2	12239-129G7	79.94	9.15
chorionic membrane cells, donor3	12240-129G8	36.82	7.14
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	88.86	7.07
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	77.03	8.45
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	132.62	15.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	162.04	17.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	172.70	17.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	189.15	25.86
chronic myelogenous leukemia cell line:K562	10454-106G4	176.38	17.37
chronic myelogenous leukemia cell line:KU812	10409-106B4	191.30	30.75
clear cell carcinoma cell line:JHOC-5	10638-108I8	101.26	5.03
clear cell carcinoma cell line:TEN	10636-108I6	50.14	7.11
colon carcinoma cell line:CACO-2	10513-107D9	41.92	9.88
colon carcinoma cell line:COLO-320	10420-106C6	104.52	34.21
colon, adult, donor1	10082-102B1	24.99	5.95
colon, adult, pool1	10014-101C5	48.76	11.87
colon, fetal, donor1	10070-101I7	26.57	8.65
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	93.49	5.52
cord blood derived cell line:COBL-a 24h infection	10453-106G3	85.73	6.94
cord blood derived cell line:COBL-a untreated	10449-106F8	106.89	9.73
corpus callosum, adult, pool1	10042-101F6	45.22	6.30
cruciate ligament, donor2	10295-104G7	45.39	13.78
diaphragm, fetal, donor1	10069-101I6	83.47	78.65
diencephalon, adult	10193-103E4	37.44	7.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	76.23	3.21
ductal cell carcinoma cell line:KLM-1	10438-106E6	78.47	8.98
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	65.72	3.37
ductus deferens, adult	10196-103E7	33.89	10.96
duodenum, fetal, donor1, tech_rep1	10071-101I8	34.57	10.08
duodenum, fetal, donor1, tech_rep2	10071-101I8	46.35	8.09
dura mater, adult, donor1	10041-101F5	41.54	8.51
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	43.53	13.99
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	111.77	16.34
embryonic pancreas cell line:1B2C6	10604-108F1	118.39	7.40
embryonic pancreas cell line:1C3D3	10605-108F2	43.59	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	89.85	3.40
embryonic pancreas cell line:2C6	10603-108E9	102.45	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	47.60	5.03
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	57.27	3.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	45.35	2.41
epidermoid carcinoma cell line:A431	10426-106D3	111.38	12.12
epidermoid carcinoma cell line:Ca Ski	10431-106D8	94.92	7.48
epididymis, adult	10197-103E8	39.14	14.65
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	56.59	2.66
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	42.47	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	103.53	18.74
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	66.14	15.06
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	118.75	17.81
esophagus, adult, pool1	10015-101C6	55.53	16.46
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	103.32	6.51
eye - muscle inferior rectus, donor1	10272-104E2	99.00	16.90
eye - muscle lateral, donor2	10298-104H1	109.42	86.27
eye - muscle medial, donor2	10299-104H2	98.22	40.18
eye - muscle superior, donor2	10297-104G9	81.40	21.78
eye - vitreous humor, donor1	10268-104D7	36.43	5.83
eye, fetal, donor1	10054-101G9	33.05	11.95
fibrosarcoma cell line:HT-1080	10758-110E2	115.91	16.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	174.50	15.43
frontal lobe, adult, pool1	10040-101F4	56.29	8.54
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	111.09	6.31
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	90.61	2.93
gall bladder, adult	10198-103E9	22.45	7.48
gamma delta positive T cells, donor1	11937-126A2	42.41	0.00
gamma delta positive T cells, donor2	11938-126A3	30.25	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	72.45	8.45
gastric adenocarcinoma cell line:MKN45	10612-108F9	111.99	6.58
gastric cancer cell line:AZ521	10549-107H9	118.38	9.02
gastric cancer cell line:GSS	10560-108A2	46.68	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	76.76	19.65
giant cell carcinoma cell line:LU65	10487-107B1	68.04	3.79
giant cell carcinoma cell line:Lu99B	10433-106E1	48.29	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	55.87	9.73
glioblastoma cell line:A172, tech_rep1	10444-106F3	42.01	3.59
glioblastoma cell line:A172, tech_rep2	10444-106F3	44.80	4.92
glioblastoma cell line:T98G	10485-107A8	51.10	3.09
glioma cell line:GI-1	10413-106B8	67.65	11.42
globus pallidus - adult, donor10196	10175-103C4	72.16	9.48
globus pallidus, adult, donor10252	10161-103A8	54.92	6.83
globus pallidus, adult, donor10258	10367-105F7	32.86	2.74
globus pallidus, newborn, donor10223	10364-105F4	31.44	5.86
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45
granulosa cell tumor cell line:KGN	10624-108H3	38.72	6.08
hIPS +CCl2, biol_rep1	14383-156B9	121.67	21.58
hIPS +CCl2, biol_rep2	14384-156C1	96.48	19.66
hIPS +CCl2, biol_rep3	14385-156C2	115.29	21.26
hIPS, biol_rep1	14380-156B6	155.23	20.12
hIPS, biol_rep2	14381-156B7	109.05	15.09
hIPS, biol_rep3	14382-156B8	75.04	7.72
hairy cell leukemia cell line:Mo	10712-109I1	79.59	4.31
heart - mitral valve, adult	10205-103F7	37.37	10.46
heart - pulmonic valve, adult	10206-103F8	50.99	17.52
heart - tricuspid valve, adult	10207-103F9	59.95	15.82
heart, adult, diseased post-infarction, donor1	10050-101G5	43.06	7.14
heart, adult, diseased, donor1	10051-101G6	29.38	7.24
heart, adult, pool1	10016-101C7	46.69	11.50
heart, fetal, pool1	10046-101G1	54.11	12.83
hepatic mesenchymal tumor cell line:LI90	10778-110G4	43.50	5.55
hepatoblastoma cell line:HuH-6	10633-108I3	122.49	45.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	64.75	13.92
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	65.54	17.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	68.01	15.46
hepatoma cell line:Li-7	10484-107A7	65.06	6.90
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	178.59	19.90
hippocampus - adult, donor10196	10169-103B7	92.74	17.98
hippocampus, adult, donor10252	10153-102I9	46.74	7.55
hippocampus, adult, donor10258	10374-105G5	46.81	5.48
hippocampus, newborn, donor10223	10363-105F3	31.72	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	159.30	41.50
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	64.21	13.94
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	85.82	21.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	38.91	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	44.41	5.94
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.34	8.35
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	52.55	7.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.90	6.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	40.46	7.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	76.48	10.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	62.84	10.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	71.37	10.77
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	56.96	16.59
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	73.69	19.65
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	118.69	38.40
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	45.63	5.54
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	51.02	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	76.96	8.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	38.43	6.41
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	41.38	5.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	50.12	6.89
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	43.27	7.35
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	44.13	9.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	48.72	7.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	65.40	15.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	67.61	13.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	98.40	25.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	62.32	9.15
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	46.56	6.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	45.39	4.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	44.47	5.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	44.50	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.35	4.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	55.99	7.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	59.06	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	57.47	8.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	71.49	15.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	81.56	17.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	90.24	12.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	55.32	6.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	494.49	65.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	73.14	5.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.99	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.77	6.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.52	7.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	46.54	7.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	84.78	10.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	52.53	5.39
immature langerhans cells, donor1	11904-125F5	71.92	17.19
immature langerhans cells, donor2	11905-125F6	19.80	13.47
insula, adult, pool1	10039-101F3	52.33	6.53
keratoacanthoma cell line:HKA-1	10791-110H8	41.62	8.45
kidney, adult, pool1	10017-101C8	46.06	8.81
kidney, fetal, pool1	10045-101F9	35.51	3.68
large cell lung carcinoma cell line:IA-LM	10509-107D5	169.15	26.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.80	12.44
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	44.41	4.40
left atrium, adult, donor1	10079-102A7	41.41	14.17
left ventricle, adult, donor1	10078-102A6	51.07	13.15
leiomyoblastoma cell line:G-402	10721-110A1	117.11	3.01
leiomyoma cell line:10964C	10569-108B2	27.66	7.90
leiomyoma cell line:15242A	10570-108B3	31.52	6.52
leiomyoma cell line:15425	10571-108B4	45.89	5.83
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	67.96	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	149.11	37.19
liposarcoma cell line:KMLS-1	10782-110G8	48.58	6.72
liposarcoma cell line:SW 872	10726-110A6	55.19	7.92
liver, adult, pool1	10018-101C9	46.35	11.67
liver, fetal, pool1	10086-102B5	15.05	7.53
locus coeruleus - adult, donor10196	10182-103D2	57.45	11.81
locus coeruleus, adult, donor10252	10165-103B3	46.32	5.35
locus coeruleus, adult, donor10258	10375-105G6	29.62	5.64
locus coeruleus, newborn, donor10223	10362-105F2	75.71	15.56
lung adenocarcinoma cell line:A549	10499-107C4	39.58	7.47
lung adenocarcinoma cell line:PC-14	10408-106B3	64.80	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	109.41	11.60
lung, adult, pool1	10019-101D1	34.38	5.08
lung, fetal, donor1	10068-101I5	80.20	27.68
lung, right lower lobe, adult, donor1	10075-102A3	32.08	4.12
lymph node, adult, donor1	10077-102A5	24.61	3.79
lymphangiectasia cell line:DS-1	10727-110A7	61.59	2.85
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	103.08	5.43
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	99.39	14.44
mature adipocyte, donor1	12231-129F8	26.20	5.77
mature adipocyte, donor2	12232-129F9	34.66	7.06
mature adipocyte, donor3	12233-129G1	27.50	6.16
mature adipocyte, donor4	12234-129G2	31.59	10.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	152.96	14.53
medial frontal gyrus - adult, donor10196	10170-103B8	83.47	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	56.09	8.28
medial frontal gyrus, adult, donor10258	10368-105F8	62.58	7.62
medial frontal gyrus, newborn, donor10223	10352-105E1	104.49	19.19
medial temporal gyrus - adult, donor10196	10183-103D3	84.04	15.69
medial temporal gyrus, adult, donor10252	10156-103A3	53.69	7.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	46.23	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	502.38	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	42.00	6.10
medulla oblongata - adult, donor10196	10174-103C3	85.02	11.68
medulla oblongata, adult, donor10252	10155-103A2	40.09	6.04
medulla oblongata, adult, pool1	10038-101F2	44.81	6.61
medulla oblongata, newborn, donor10223	10361-105F1	36.45	3.82
medulloblastoma cell line:D283 Med	10838-111E1	106.28	31.88
medulloblastoma cell line:ONS-76	10759-110E3	91.70	7.21
melanoma cell line:COLO 679	10514-107E1	62.96	13.08
melanoma cell line:G-361	10465-106H6	70.31	5.70
meningioma cell line:HKBMM	10691-109F7	25.69	2.35
merkel cell carcinoma cell line:MKL-1	10843-111E6	108.38	14.10
merkel cell carcinoma cell line:MS-1	10844-111E7	146.98	20.22
mesenchymal precursor cell - adipose, donor1	11747-123G1	76.72	18.41
mesenchymal precursor cell - adipose, donor2	11748-123G2	44.54	16.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.82	13.25
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	38.49	10.11
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	40.82	9.24
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	24.29	6.25
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.70	10.64
mesenchymal precursor cell - cardiac, donor2	11753-123G7	41.98	8.40
mesenchymal precursor cell - cardiac, donor3	11754-123G8	61.15	16.98
mesenchymal precursor cell - cardiac, donor4	11755-123G9	69.01	10.67
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	64.16	12.95
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	36.89	8.89
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	57.56	9.82
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	57.95	8.38
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	41.45	5.31
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	28.76	4.31
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	31.24	6.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	24.62	5.47
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	104.89	17.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	45.58	7.92
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	41.40	9.28
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	36.82	7.73
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.91	5.15
mesenchymal stem cell line:Hu5/E18	10568-108B1	91.36	15.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.01	11.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	35.55	10.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	38.74	9.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	38.20	10.17
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	43.07	15.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	41.97	14.55
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.33	9.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	34.75	6.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.59	14.13
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	36.14	9.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	30.28	10.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	46.20	13.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	31.55	12.75
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	35.62	13.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	28.78	10.74
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	13.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	35.08	14.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	39.28	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	34.12	6.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	33.53	10.63
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.54	13.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	33.58	8.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	10.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	30.83	10.08
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	8.53
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	40.54	14.57
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.42	11.73
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	12.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	13.78
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.04	8.96
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	11.92
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	25.94	12.97
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.12	12.78
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	41.39	16.56
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	25.68
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	42.68	16.52
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	62.84	12.86
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	40.37	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	61.06	15.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	53.60	8.87
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	40.55	15.20
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	53.41	13.96
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	46.13	8.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	46.43	14.68
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	52.57	8.76
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	38.71	7.13
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.04	10.83
mesothelioma cell line:ACC-MESO-1	10493-107B7	108.67	2.36
mesothelioma cell line:ACC-MESO-4	10494-107B8	71.59	6.49
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	72.85	13.97
mesothelioma cell line:Mero-25	10850-111F4	37.90	5.67
mesothelioma cell line:Mero-41	10851-111F5	103.17	7.82
mesothelioma cell line:Mero-48a	10852-111F6	65.76	6.86
mesothelioma cell line:Mero-82	10853-111F7	55.19	9.99
mesothelioma cell line:Mero-83	10854-111F8	48.51	10.55
mesothelioma cell line:Mero-84	10855-111F9	19.21	4.30
mesothelioma cell line:Mero-95	10856-111G1	46.79	10.56
mesothelioma cell line:NCI-H2052	10847-111F1	62.61	8.61
mesothelioma cell line:NCI-H226	10846-111E9	70.77	12.49
mesothelioma cell line:NCI-H2452	10848-111F2	67.82	8.03
mesothelioma cell line:NCI-H28	10845-111E8	58.53	5.60
mesothelioma cell line:No36	10857-111G2	55.45	4.24
mesothelioma cell line:ONE58	10858-111G3	79.66	21.13
migratory langerhans cells, donor1	11901-125F2	33.20	2.69
migratory langerhans cells, donor2	11902-125F3	39.69	1.34
migratory langerhans cells, donor3	11903-125F4	55.46	4.13
mixed mullerian tumor cell line:HTMMT	10689-109F5	58.44	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	70.36	6.57
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	140.98	9.91
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	47.57	4.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	145.99	13.67
myeloma cell line:PCM6	10474-106I6	55.35	3.36
myxofibrosarcoma cell line:MFH-ino	10600-108E6	62.90	9.64
myxofibrosarcoma cell line:NMFH-1	10684-109E9	75.51	9.61
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.54	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.54	1.91
nasal epithelial cells, donor2	12227-129F4	35.33	2.21
neuroblastoma cell line:CHP-134	10508-107D4	60.97	23.01
neuroblastoma cell line:NB-1	10539-107G8	74.27	10.85
neuroblastoma cell line:NBsusSR	10607-108F4	277.53	40.91
neuroblastoma cell line:NH-12	10555-107I6	41.00	13.04
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	51.24	21.11
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	62.72	12.20
neuroectodermal tumor cell line:TASK1	10774-110F9	72.86	11.67
neuroepithelioma cell line:SK-N-MC	10728-110A8	111.26	11.44
neurofibroma cell line:Hs 53.T	10729-110A9	53.23	7.72
neutrophil PMN, donor1	12133-128D9	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	127.01	10.15
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	67.24	12.01
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	48.73	7.37
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	38.89	3.15
nucleus accumbens, adult, pool1	10037-101F1	50.90	6.19
occipital cortex - adult, donor10196	10172-103C1	111.26	18.54
occipital cortex, adult, donor10252	10163-103B1	55.82	7.51
occipital cortex, newborn, donor10223	10355-105E4	37.85	7.64
occipital lobe, adult, donor1	10076-102A4	50.91	6.82
occipital lobe, fetal, donor1	10073-102A1	84.96	22.74
occipital pole, adult, pool1	10036-101E9	33.35	3.00
olfactory region, adult	10195-103E6	46.43	6.88
optic nerve, donor1	10277-104E7	48.03	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	46.82	4.56
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	68.28	2.20
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	67.90	9.48
oral squamous cell carcinoma cell line:SAS	10544-107H4	45.51	14.44
osteoclastoma cell line:Hs 706.T	10704-109H2	34.69	5.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	182.20	28.96
osteosarcoma cell line:HS-Os-1	10558-107I9	98.18	15.69
ovary, adult, pool1	10020-101D2	46.91	12.93
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	101.56	10.27
pancreas, adult, donor1	10049-101G4	31.98	12.23
pancreatic carcinoma cell line:NOR-P1	10698-109G5	39.41	8.67
papillary adenocarcinoma cell line:8505C	10437-106E5	54.68	5.79
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	69.21	6.62
paracentral gyrus, adult, pool1	10035-101E8	48.96	4.76
parietal cortex, adult, donor10258	10373-105G4	55.78	5.14
parietal lobe - adult, donor10196	10171-103B9	79.00	12.23
parietal lobe, adult, donor10252	10157-103A4	53.30	5.70
parietal lobe, adult, pool1	10034-101E7	41.33	4.41
parietal lobe, fetal, donor1	10072-101I9	68.86	26.19
parietal lobe, newborn, donor10223	10356-105E5	48.98	5.23
parotid gland, adult	10199-103F1	46.25	27.75
penis, adult	10200-103F2	50.49	38.67
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.57	17.85
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	39.34	3.06
pineal gland - adult, donor10196	10179-103C8	183.83	36.12
pineal gland, adult, donor10252	10160-103A7	116.07	31.39
pineal gland, adult, donor10258	10377-105G8	89.04	27.59
pituitary gland - adult, donor10196	10180-103C9	108.26	28.33
pituitary gland, adult, donor10252	10162-103A9	102.15	17.20
pituitary gland, adult, donor10258	10378-105G9	43.41	5.96
placenta, adult, pool1	10021-101D3	53.43	7.63
plasma cell leukemia cell line:ARH-77	10840-111E3	59.06	1.99
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	50.58	10.89
pons, adult, pool1	10033-101E6	57.15	7.32
postcentral gyrus, adult, pool1	10032-101E5	41.15	4.79
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	22.03
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74
prostate cancer cell line:DU145	10490-107B4	66.13	4.37
prostate cancer cell line:PC-3	10439-106E7	105.45	7.26
prostate, adult, pool1	10022-101D4	55.23	20.68
putamen, adult, donor10196	10176-103C5	55.00	9.91
putamen, adult, donor10252	10152-102I8	58.82	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	56.83	7.65
putamen, adult, donor10258, tech_rep2	10372-105G3	44.70	4.59
putamen, newborn, donor10223	10365-105F5	98.96	7.50
rectal cancer cell line:TT1TKB	10469-106I1	78.55	9.02
rectum, fetal, donor1	10067-101I4	93.20	25.04
renal cell carcinoma cell line:OS-RC-2	10411-106B6	76.11	3.18
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	35.21	2.07
retina, adult, pool1	10030-101E3	42.94	8.75
retinoblastoma cell line:Y79	10475-106I7	138.47	46.76
rhabdomyosarcoma cell line:KYM-1	10787-110H4	69.83	6.64
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	248.86	45.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	54.57	15.16
salivary acinar cells, donor1	11771-123I7	41.27	8.90
salivary acinar cells, donor2	11772-123I8	27.12	12.39
salivary acinar cells, donor3	11773-123I9	44.36	7.94
salivary gland, adult, pool1	10093-102C3	42.90	23.45
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	87.94	7.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	100.86	6.11
seminal vesicle, adult	10201-103F3	39.68	9.52
serous adenocarcinoma cell line:JHOS-2	10639-108I9	62.19	12.88
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	32.96	10.82
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	60.21	6.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.80	3.49
signet ring carcinoma cell line:Kato III	10436-106E4	81.46	3.54
signet ring carcinoma cell line:NUGC-4	10483-107A6	39.35	9.29
skeletal muscle - soleus muscle, donor1	10282-104F3	305.01	90.79
skeletal muscle, adult, pool1	10023-101D5	177.99	88.51
skeletal muscle, fetal, donor1	10066-101I3	74.37	40.20
skin, adult, donor1	10074-102A2	20.36	0.00
skin, fetal, donor1	10065-101I2	54.92	23.36
small cell cervical cancer cell line:HCSC-1	10800-110I8	65.04	7.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	79.75	16.08
small cell lung carcinoma cell line:DMS 144	10841-111E4	115.46	5.01
small cell lung carcinoma cell line:LK-2	10541-107H1	80.11	16.98
small cell lung carcinoma cell line:NCI-H82	10842-111E5	149.43	50.67
small cell lung carcinoma cell line:WA-hT	10562-108A4	144.70	25.28
small intestine, adult, pool1	10024-101D6	46.22	10.63
small intestine, fetal, donor1	10064-101I1	44.96	12.04
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	26.67	6.67
smooth muscle, adult, pool1	10048-101G3	64.61	31.01
somatostatinoma cell line:QGP-1	10781-110G7	95.68	15.55
spinal cord - adult, donor10196	10181-103D1	66.76	22.71
spinal cord, adult, donor10252	10159-103A6	72.55	13.41
spinal cord, adult, donor10258	10369-105F9	83.02	18.68
spinal cord, fetal, donor1	10056-101H2	48.18	10.37
spinal cord, newborn, donor10223	10359-105E8	83.12	20.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	49.14	5.23
spleen, adult, pool1	10025-101D7	49.89	7.38
spleen, fetal, pool1	10044-101F8	41.00	5.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	49.17	4.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.60	2.85
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	64.65	6.64
squamous cell carcinoma cell line:T3M-5	10616-108G4	126.66	6.25
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	76.20	6.75
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	57.19	7.62
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	46.11	4.65
stomach, fetal, donor1	10062-101H8	71.55	18.16
submaxillary gland, adult	10202-103F4	46.71	15.38
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	36.97	9.35
substantia nigra, adult, donor10258	10371-105G2	56.38	11.38
substantia nigra, newborn, donor10223	10358-105E7	36.04	7.77
synovial sarcoma cell line:HS-SY-II	10441-106E9	97.44	9.63
temporal lobe, adult, pool1	10031-101E4	34.42	3.98
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	66.24	15.67
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	48.79	11.43
tenocyte, donor1	11763-123H8	48.18	10.12
tenocyte, donor2	11765-123I1	24.80	4.96
tenocyte, donor3	11768-123I4	37.81	9.27
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	179.65	21.75
teratocarcinoma cell line:NCR-G1	10798-110I6	79.69	9.56
teratocarcinoma cell line:PA-1	10807-111A6	60.13	13.95
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	119.20	17.52
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	190.22	29.12
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	105.35	37.95
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	120.84	19.87
testis, adult, pool1	10026-101D8	72.48	15.35
testis, adult, pool2	10096-102C6	71.27	9.02
thalamus - adult, donor10196	10168-103B6	98.25	7.73
thalamus, adult, donor10252	10154-103A1	40.63	6.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	64.66	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.31	4.78
thalamus, newborn, donor10223	10366-105F6	49.48	9.21
throat, adult	10209-103G2	70.91	48.94
throat, fetal, donor1	10061-101H7	66.43	35.04
thymic carcinoma cell line:Ty-82	10803-111A2	97.78	17.69
thymus, adult, pool1	10027-101D9	58.46	7.16
thymus, fetal, pool1	10043-101F7	49.15	6.13
thyroid carcinoma cell line:KHM-5M	10776-110G2	64.88	9.84
thyroid carcinoma cell line:TCO-1	10783-110G9	111.61	13.55
thyroid, adult, pool1	10028-101E1	46.28	8.40
thyroid, fetal, donor1	10060-101H6	41.13	9.76
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	24.64
tongue, adult	10203-103F5	77.68	50.00
tongue, fetal, donor1	10059-101H5	109.95	87.88
tonsil, adult, pool1	10047-101G2	44.48	5.81
trachea, adult, pool1	10029-101E2	52.27	11.04
trachea, fetal, donor1	10058-101H4	50.01	18.47
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	71.92	7.09
transitional-cell carcinoma cell line:5637	10418-106C4	100.81	11.45
transitional-cell carcinoma cell line:JMSU1	10492-107B6	91.98	8.77
tridermal teratoma cell line:HGRT	10694-109G1	129.37	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.97	8.80
umbilical cord, fetal, donor1	10057-101H3	37.56	6.26
uterus, adult, pool1	10100-102D1	57.50	14.67
uterus, fetal, donor1	10055-101H1	52.22	18.43
vagina, adult	10204-103F6	42.65	12.92
vein, adult	10191-103E2	30.03	6.36
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.91	3.20